Showing results (301-310 of 343) with videos related to
Sort By:
Pageof 35
British Journal of Pharmacology|November 1, 1996
The effects of SB 216469, an antagonist which discriminates between the alpha 1A-adrenoceptor and the human prostatic alpha 1-adrenoceptorR Chess-Williams, C R Chapple, F Verfurth, et al.European Journal of Biochemistry|February 1, 1996
Translocation of microfilament-associated inhibitory guanine-nucleotide-binding proteins to the plasma membrane in myeloid differentiated human leukemia (HL-60) cellsD Meyer zu Heringdorf, K Liedel, S Kaldenberg-Stasch, et al.Journal of Cardiovascular Pharmacology|March 1, 1989
Alpha and beta-adrenoceptors in hypertension. I. Cardiac and renal alpha 1-, beta 1-, and beta 2-adrenoceptors in rat models of acquired hypertensionM C Michel, R Kanczik, M Khamssi, et al.The American Journal of Physiology|June 5, 1998
Growth factor-like action of lysophosphatidic acid on human B lymphoblastsD Rosskopf, W Daelman, S Busch, et al.Journal of Cardiovascular Pharmacology|September 1, 1992
Terbutaline-induced desensitization of beta 2-adrenoceptor in vivo function in humans: attenuation by ketotifenO E Brodde, S Petrasch, H J Bauch, et al.European Heart Journal|June 1, 1989
Beta-adrenoceptor regulation in the human heart: can it be monitored in circulating lymphocytes?O E Brodde, M C Michel, E P Gordon, et al.International Journal of Clinical Practice|November 26, 2009
How are women with SUI-symptoms treated with duloxetine in real life practice? - preliminary results from a large observational study in GermanyM Manning, U Gotsch, A Minarzyk, et al.Journal of Cardiovascular Pharmacology|February 1, 1992
Spare receptors for beta-adrenoceptor-mediated positive inotropic effects of catecholamines in the human heartL Brown, N M Deighton, S Bals, et al.Journal of Autonomic Pharmacology|September 5, 1998
Thyroid status affects the rat cardiac beta-adrenoceptor system transiently and time-dependentlyJ Zwaveling, H D Batink, K Taguchi, et al.Molecular Pharmacology|January 1, 1990
Nonadrenergic [3H]idazoxan binding sites are physically distinct from alpha 2-adrenergic receptorsM C Michel, J W Regan, M A Gerhardt, et al.Pageof 35